Nanovectorized radiotherapy by convection-enhanced delivery (CED), a promising strategy that demonstrates high efficacy in a murine model of human endometrial adenocarcinoma by A. Genin et al.
Nanovectorized radiotherapy by convection-enhanced
delivery (CED), a promising strategy that demonstrates high
efficacy in a murine model of human endometrial
adenocarcinoma
Submitted by Franck Lacoeuille on Fri, 07/03/2015 - 11:23
Titre
Nanovectorized radiotherapy by convection-enhanced delivery (CED), a promising
strategy that demonstrates high efficacy in a murine model of human endometrial
adenocarcinoma
Type de
publication Communication
Type Communication avec actes dans un congrès
Année 2015
Langue Anglais
Date du
colloque 10-14/10/2015
Titre du
colloque
Do.MoRe – 6th International Symposium on DOsimetry and MOlecular Radiotherapy
during 28th Annual Congress of the European Association of Nuclear Medicine
Auteur
genin, ambroise [1], Lefebvre-Lacoeuille, Céline [2], Rousseau, J [3], Chouin, N. [4],
Fosse, Pacôme [5], Dabli, D [6], Bouchet, Francis [7], Lepareur, Nicolas [8],
Descamps, Philippe [9], Hindré, François [10], Couturier, Olivier-François [11],
Lacœuille, Franck [12]
Pays Allemagne
Ville Hambourg
Résumé en
anglais
Aim: To evaluate the biodistribution, the toxicity, the dosimetry and the antitumor
efficacy of intra-tumoral injection of rhenium-188 loaded nanoparticles (LNC-188Re-
SSS) by CED. Materials and methods: Ishikawa endometrial carcinoma cell lines were
implanted subcutaneously in nude mice (n=70). For biodistribution and efficacy
studies CED procedure was realized at D28 after tumour implantation. CED was
performed using an osmotic pump (0.5μL/min for 20 minutes) after immobilisation of
anaesthetized mice on a stereotactic frame. For biodistribution studies, animals
(n=30) were injected by CED either with 3MBq of 188ReO4- (n=15) or LNC-188Re-
SSS (n=15) and sacrificed at 1h (n=10), 24h (n=10) or 72h (n=10). For efficacy
studies, control group mice were injected by CED with saline (n=8) or blank LNC
(n=8) and treated group mice were injected with escalating dose of LNC-188Re-SSS:
3MBq (n=8), 6 MBq (n=8) or 12 MBq (n=8). Efficacy on tumour growth was assessed
by clinical palpation and μMRI. The time for the tumour volume doubling was chosen
as endpoint, leading to the euthanasia of the animal. The physical dose deposited in
the tumour for each treated animal was estimated by Monte Carlo simulation (Geant4)
using measured biodistribution and μMRI tumour volumes,. Haematological toxicity in
mice was evaluated using blood sampling of 50μL (retro-orbital sinus) at D2, D7, D14
and D21 after treatment with saline (n=4) and after treatment with LNC-188Re-SSS,
3MBq (n=4), 6 MBq (n=4) or 12 MBq (n=4). Results: Nanovectorization of 188Re
combined with CED allowed the confinement of more than 30 % of ID in the tumour
limiting therefore urinary excretion of 188Re since 0,1% versus 81,9% of ID were
excreted in urine 24h after CED of LNC-188Re-SSS and 188ReO4- respectively
(p=0.016). Nanovectorized radiotherapy has drastically increased the median survival
time compared with control group. Animals whose tumor received a dose higher than
69 Gy (69-340 Gy) showed an ISTmedian of + 933%, whereas animals whose tumor
received a dose lower than 69 Gy (21-67Gy) showed an ISTmedian of + 391%.
Complete response with eradication of the tumor was observed in 4/12 (33.3%)
animals of the former group. Depletion of platelets was observed following
LNC-188Re-SSS injection with a time to nadir between D14-D21 whereas transient
lymphocyte depletion was only observed at D7 for the highest administered activities
(12MBq).
Conclusion: CED of LNC-188Re-SSS demonstrates interesting biodistribution
properties and high efficacy in a model of human endometrial carcinoma.
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